Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res Dev Brain Res ; 156(2): 111-26, 2005 May 12.
Article in English | MEDLINE | ID: mdl-16099299

ABSTRACT

The effects of brain-derived neurotrophic factor (BDNF) on the development of presynaptic terminals and of neuronal subtypes in various brain areas were studied in BDNF-knockout (BDNF-/-) mice at postnatal days 15-17. Western analysis revealed no changes in the overall amount of a variety of synaptic proteins in BDNF-/- mice as compared to wild type mice. In addition, the complex between the vesicular proteins, synaptophysin and synaptobrevin, as well as their respective homodimers were unaltered. Moreover, no changes in the density of neurons were found in, e.g., the CA3 region of the hippocampus and the nucleus nervi facialis of BDNF-/- mice. However, cholinergic cells were reduced by 20% in the medial septum of BDNF-/- mice associated with a decrease in the activity of choline acetyltransferase and protein levels of nerve growth factor in the hippocampus by 16% and 44%, respectively. In the striatum, however, the total number of cholinergic cells were comparable in both groups, although the activity of choline acetyltransferase was decreased by 46%. In GABAergic interneurons, the expression of neuropeptides in various brain areas was differentially affected by BDNF deletion as revealed by immunohistochemistry. In the hippocampus and cortex of BDNF-/- mice, the density of neuropeptide Y-, somatostatin-, and parvalbumin-immunoreactive cells was drastically reduced, whereas the density of calretinin-positive cells was increased. The extent of these changes in neuropeptide-containing cells varied among hippocampal subregions. In the striatum, only the density of parvalbumin-immunoreactive cells was decreased by approximately 45%. In conclusion, BDNF deficiency is accompanied by a differential dysregulation in the expression of neuropeptides and calcium-binding proteins in otherwise intact GABAergic and glutamatergic neurons in a region-specific manner.


Subject(s)
Brain-Derived Neurotrophic Factor/deficiency , Brain/cytology , Brain/metabolism , Neurons/classification , Neurons/metabolism , Age Factors , Animals , Animals, Newborn , Blotting, Western/methods , Brain/growth & development , Brain Chemistry , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/physiology , Calbindin 2 , Cell Count/methods , Choline O-Acetyltransferase/metabolism , Enzyme-Linked Immunosorbent Assay/methods , Glutamate Decarboxylase/metabolism , Immunohistochemistry/methods , Immunoprecipitation/methods , Isoenzymes/metabolism , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Growth Factors/metabolism , Neurons/cytology , Neuropeptide Y/metabolism , Parvalbumins/metabolism , R-SNARE Proteins , S100 Calcium Binding Protein G/metabolism , Somatostatin/metabolism , Synaptophysin/metabolism
2.
J Neurochem ; 90(1): 1-8, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15198661

ABSTRACT

Synaptophysin is one of the most abundant membrane proteins of small synaptic vesicles. In mature nerve terminals it forms a complex with the vesicular membrane protein synaptobrevin, which appears to modulate synaptobrevin's interaction with the plasma membrane-associated proteins syntaxin and SNAP25 to form the SNARE complex as a prerequisite for membrane fusion. Here we show that synaptobrevin is preferentially cleaved by tetanus toxin while bound to synaptophysin or when existing as a homodimer. The synaptophysin/synaptobrevin complex is, however, not affected when neuronal secretion is blocked by botulinum A toxin which cleaves SNAP25. Excessive stimulation with alpha-latrotoxin or Ca(2+)-ionophores dissociates the synaptophysin/synaptobrevin complex and increases the interaction of the other SNARE proteins. The stimulation-induced dissociation of the synaptophysin/synaptobrevin complex is not inhibited by pre-incubating neurones with botulinum A toxin, but depends on extracellular calcium. However, the synaptophysin/synaptobrevin complex cannot be directly dissociated by calcium alone or in combination with magnesium. The dissociation of synaptobrevin from synaptophysin appears to precede its interaction with the other SNARE proteins and does not depend on the final fusion event. This finding further supports the modulatory role the synaptophysin/synaptobrevin complex may play in mature neurones.


Subject(s)
Exocytosis/physiology , Membrane Proteins/metabolism , Neurons/metabolism , Synaptophysin/metabolism , Animals , Botulinum Toxins, Type A/pharmacology , Brain Chemistry , Calcium/metabolism , Cells, Cultured , Dimerization , Exocytosis/drug effects , Hippocampus/cytology , Ionophores/pharmacology , Macromolecular Substances , Magnesium/pharmacology , Membrane Proteins/chemistry , Membrane Proteins/drug effects , Mice , Nerve Tissue Proteins/drug effects , Nerve Tissue Proteins/metabolism , Neurons/cytology , Neurons/drug effects , Protein Binding/drug effects , R-SNARE Proteins , Rats , Spider Venoms/pharmacology , Stimulation, Chemical , Synaptophysin/chemistry , Synaptosomal-Associated Protein 25 , Synaptosomes/chemistry , Synaptosomes/drug effects , Tetanus Toxin/chemistry , Tetanus Toxin/pharmacology
3.
Hum Genet ; 112(1): 50-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12483299

ABSTRACT

Mal de Meleda (MDM) or keratosis palmoplantaris transgrediens of Siemens is an autosomal recessive skin disorder characterized by diffuse palmoplantar keratoderma (PPK) and transgressive keratosis with an onset in early infancy. There is no associated involvement of other organs; however, a spectrum of clinical presentations with optional and variable features has been described. Mutations in the ARS (component B)-81/s gene ( LY6LS) on chromosome 8q24-qter, which encodes SLURP-1, have recently been identified in patients with MDM. Here, we have analyzed four MDM families for mutations in SLURP-1. In a large Palestinian pedigree with multiple consanguinity, patients are homozygous for a new mutation that substitutes an arginine for a conserved glycine residue at position 86. A different mutation in Turkish patients results in the same amino acid exchange. Some remarkable similarities are seen in the clinical picture of patients from both families. Patients of an Emirati Bedouin family have a homozygous alteration of the translation initiation codon. In a German family with no known consanguinity, we have shown pseudodominant inheritance. Three affected children and their affected mother are homozygous for the missense mutation W15R. Our findings indicate that the MDM type of transgressive PPK is caused by SLURP-1 mutations in patients from various origins and demonstrate allelic heterogeneity for mutations in SLURP-1.


Subject(s)
Antigens, Ly/genetics , Keratoderma, Palmoplantar/genetics , Mutation , Urokinase-Type Plasminogen Activator/genetics , Adult , Amino Acid Substitution , Arginine/metabolism , Chromosomes, Human, Pair 8 , Consanguinity , Female , Genes, Recessive , Genetic Heterogeneity , Germany , Haplotypes , Homozygote , Humans , Infant , Keratoderma, Palmoplantar/complications , Keratoderma, Palmoplantar/etiology , Keratoderma, Palmoplantar/pathology , Male , Mutation, Missense , Pedigree , Point Mutation , Turkey/ethnology , United Arab Emirates
4.
J Neurochem ; 84(1): 35-42, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12485399

ABSTRACT

Synaptophysin interacts with synaptobrevin in membranes of adult small synaptic vesicles. The synaptophysin/synaptobrevin complex promotes synaptobrevin to built up functional SNARE complexes thereby modulating synaptic efficiency. Synaptophysin in addition is a cholesterol-binding protein. Depleting the membranous cholesterol content by filipin or beta-methylcyclodextrin (beta-MCD) decreased the solubility of synaptophysin in Triton X-100 with less effects on synaptobrevin. In small synaptic vesicles from rat brain the synaptophysin/synaptobrevin complex was diminished upon beta-MCD treatment as revealed by chemical cross-linking. Mice with a genetic mutation in the Niemann-Pick C1 gene developing a defect in cholesterol sorting showed significantly reduced amounts of the synaptophysin/synaptobrevin complex compared to their homo- or heterozygous littermates. Finally when using primary cultures of mouse hippocampus the synaptophysin/synaptobrevin complex was down-regulated after depleting the endogenous cholesterol content by the HMG-CoA-reductase inhibitor lovastatin. Alternatively, treatment with cholesterol up-regulated the synaptophysin/synaptobrevin interaction in these cultures. These data indicate that the synaptophysin/synaptobrevin interaction critically depends on a high cholesterol content in the membrane of synaptic vesicles. Variations in the availability of cholesterol may promote or impair synaptic efficiency by interfering with this complex.


Subject(s)
Cholesterol/metabolism , Membrane Proteins/metabolism , Synaptophysin/metabolism , Animals , Anticholesteremic Agents/pharmacology , Brain/metabolism , CHO Cells , Cholesterol/pharmacology , Cricetinae , Cyclodextrins/pharmacology , Detergents , Filipin/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Lovastatin/pharmacology , Membranes/metabolism , Mice , Mice, Inbred BALB C , Niemann-Pick Diseases/genetics , Niemann-Pick Diseases/metabolism , Octoxynol , Protein Transport , R-SNARE Proteins , Rats , Solubility , Synaptic Vesicles/metabolism , Synaptophysin/chemistry , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...